Building Human In Vitro 3D Models to Replace Animal Studies During Drug Discovery Research: Scientific, Ethical and Regulatory Considerations-Reference-Cited by-同舟云学术

Building Human In Vitro 3D Models to Replace Animal Studies During Drug Discovery Research: Scientific, Ethical and Regulatory Considerations

Published:2022 Issue: Volume: Page:695-717
ISSN:
Container-title:Microfluidics and Multi Organs on Chip
language:
Short-container-title:

Author:

Vangala Subrahmanyam,Saxena Uday,Satish Chandran C.

Publisher

Springer Nature Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-19-1379-2_29

Reference49 articles.

1. Hägglöf I, Holmgren Å (2012) Chapter 20 - Regulatory affairs. In: Hill RG, Rang HP (eds) Drug discovery and development, 2nd edn. Elsevier, Amsterdam, pp 285–301

2. Moyer ED (2006) Chapter 12 - Regulatory affairs: keeping product development on track. In: Robbins-Rot C (ed) Alternative careers in science, 2nd edn. Elsevier, Amsterdam, pp 125–138

3. Ethical Issues in Drug Development | Stanford eCorner (2011)

4. Preziosi P (2004) Science, pharmacoeconomics and ethics in drug R & D: a sustainable future scenario? Nat Rev Drug Discov 3:521–526

5. Klein AV. Ethics in Clinical Trials and Drug Development. Ready to fulfil its Destiny? Ethics in Clinical Trials and Drug Development (pharmafocusasia.com)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022;Alternatives to Laboratory Animals;2023-06-06

2. Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 2021;Alternatives to Laboratory Animals;2022-03